|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis显示文摘 | Tashiro J Elliot SJ Gerth DJ | 2015 | Transl Res2015，166，6： | 1 |
| 2 | Identification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide elimination 显示文摘 | Elliot DJ Suharjono Lewis BC | 2007 | Br J Clin Pharmacol2007，64，4： | 1 |
| 3 | Morphine glu- curonidation and glucosidation represent complemen- tary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7 : kinetic, inhibition, and molecular modeling studies显示文摘 | Chau N Elliot DJ Lewis BC et ol | 2014 | Pharmacol Exp Ther2014，349，1： | 1 |
| 4 | An evaluation of poten- tial mechanism-based inactivation of human drug metabolizing cy- tochromes P450 by monoamine oxidase inbibitors,including isonia- zid显示文摘 | Polasek TM Elliot DJ Somogyi AA | 2006 | Br J Clin PharmacoI2006，61，5： | 1 |
| 5 | In vizro character ization of lamotrigine N2-glucuronidation and the lamotrigine- valproic acid interaction 显示文摘 | Rowland A Elliot DJ Williams JA etal | 2006 | Drug Metab Dispos2006，34，： | 1 |
| 6 | The glucuronida tion of Delta4-3-Keto C19 and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltrans- ferases (UGTs) : 6alpha- and 21-hydroxyprogesterone are se- lective substrates for UGT2B7显示文摘 | Bowalgaha K Elliot DJ Mackenzie Ph | 2007 | Drug Metab Dispos2007，35，3： | 1 |
| 7 | Se lectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, heco genin, phenylbutazone, quinidine, quinine, and sul finpyrazone) 'probes' for human udp-glucuronosyltransferases显示文摘 | Uchaipichat V Mackenzie PI Elliot DJ | 2006 | Drug Metab Dispos2006，34，3： | 1 |
| 8 | In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction显示文摘 | ROWLAND A ELLIOT DJ WILLIAMS JA | 2006 | Drug Metab Dispos2006，34，6： | 1 |
| 9 | In vitro character- ization of lamotrigine N2-glueuronidation and the lamotrigine- valproic acid interaction显示文摘 | Rowland A Elliot DJ Williams JA | 2006 | Drug Metab Dispos2006，34，6： | 1 |
| 10 | S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP- glucuronosyltrans ferases (UGT): role of UGT2B7 in the elimination of naproxen 显示文摘 | Bowalgaha K Elliot DJ Mackenzie PI | 2005 | Br J Clin Pharmacol2005，60，4： | 1 |
| 11 | In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine- valproic acid interaction 显示文摘 | ROWLAND A ELLIOT DJ WILLIAMS JA | 2006 | Drug Metab Dispos2006，34，6： | 1 |
| 12 | Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glueuronosyltransferase 1A substrates 显示文摘 | Udomuksorn W Elliot DJ Lewis BC | 2007 | Pharmacogenet Genomics2007，17，12： | 1 |
| 13 | In vitro character ization of lamotrigine N2-glucuronidation and the lamotrigine- valproic acid interaction显示文摘 | Rowland A Elliot DJ Williams JA | 2006 | Drug Metab Dispos2006，34，6： | 1 |
| 14 | Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro显示文摘 | Polasek TM Elliot DJ Lewis BC | 2004 | J Pharmacol Exp Ther2004，311，3： | 1 |
| 15 | In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction显示文摘 | Rowland A Elliot DJ Williams JA | 2006 | Drug Metab Dispos2006，34，： | 1 |
| 16 | An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid显示文摘 | Polasek TM Elliot DJ Somogyi AA | 2006 | Br J Clin Pharmacol2006，61，5： | 1 |
| 17 | In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valpmic acid interaction 显示文摘 | Rowland A Elliot DJ Williams JA | 2006 | Drug Metab Dispos2006，34，： | 1 |
| 18 | In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction显示文摘 | Rowland A Elliot DJ Williams JA | 2006 | Drug Metab Dispos2006，34，6： | 1 |
| 19 | Influence of mutations associated with Gilbert and Crigler-Najjar typeⅡsyndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1 A substrates显示文摘 | Udomuksorn W Elliot DJ Lewis BC | 2007 | Pharrnacogenet Genomics2007，17，12： | 1 |
| 20 | Influence of mutations associated with Gilbert and Crigler-Najjar typeⅡsyndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates显示文摘 | Udomuksorn W Elliot DJ Lewis BC | 2007 | Pharmacogenet Genomics2007，17，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员